EDIGO BIOINFORMATICS

Serial Number 88137290
Registration 6070251
700

Registration Progress

Application Filed
Sep 29, 2018
Under Examination
Apr 2, 2019
Approved for Publication
Feb 5, 2019
Published for Opposition
Feb 5, 2019
Registered
Jun 2, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-02)
Due: Jun 02, 2026 314 days

Trademark Image

EDIGO BIOINFORMATICS

Basic Information

Serial Number
88137290
Registration Number
6070251
Filing Date
September 29, 2018
Registration Date
June 2, 2020
Published for Opposition
February 5, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 2, 2020
Registration
Registered
Classes
042

Rights Holder

EDIGENE INC

03
Address
LIFE SCIENCE PARK
22 KEXUEYUAN ROAD
BEIJING 102206
CN

Ownership History

EDIGENE INC

Original Applicant
03
BEIJING CN

EDIGENE INC

Owner at Publication
03
BEIJING CN

EDIGENE INC

Original Registrant
03
BEIJING CN

Legal Representation

Attorney
Nihat Deniz Bayramoglu

USPTO Deadlines

Next Deadline
314 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-02)
Due Date
June 02, 2026
Grace Period Ends
December 02, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Jun 2, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 2, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 25, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 24, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 22, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 22, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 17, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 21, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 21, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 21, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 21, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 21, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 21, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 17, 2019 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Oct 17, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 17, 2019 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 3, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 3, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 11, 2019 IUAF S USE AMENDMENT FILED Loading...
Sep 11, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 2, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 10, 2019 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 16, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 28, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 7, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 6, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 6, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 6, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 6, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 4, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 7, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 3, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
First Use Anywhere: Aug 7, 2018
First Use in Commerce: Aug 8, 2018

Additional Information

Pseudo Mark
EDI GO BIOINFORMATICS

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOINFORMATICS"